This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Veterinary Therapeutic Protein and Peptide Sequence Optimization
BioVenic provides veterinary therapeutic protein and peptide sequence optimization services that enhance the pharmacological properties of biomolecules for preclinical research, supporting veterinary drug discovery, lead optimization, and tailored therapeutic development across companion animals, livestock, poultry, and aquatic species. Our platform covers molecular modeling—protein structure prediction, docking and dynamic simulations, and functional annotation, plus peptide conformation analysis, binding-affinity studies, and stability assessments—and point mutation techniques including mutation-impact analysis, protein re-engineering, functional and stability testing, and peptide activity, stability, and solubility optimization. We support researchers with advanced bioinformatics-driven sequence optimization that improves receptor affinity, stability, and reduces immunogenicity, delivering detailed analytical reports, iterative testing, and comprehensive after-sales assistance to maximize therapeutic efficacy and safety.
Protein and Peptide Sequence Optimization Overview
Veterinary protein and peptide sequence optimization is critical for drug discovery and preclinical research, focusing on enhancing the properties of proteins and peptides for various applications. Compared with structure optimization, it has some obvious advantages, such as feasibility, high efficiency, direct impact on functionality, and scalability. Structure optimization is more dependent on the availability of high-resolution structure data, which is not always available for all proteins of interest. Meanwhile, manipulating protein structures can sometimes lead to unforeseen changes in protein dynamics and function, as some changes can have large ripple effects on a protein's overall structure. Thus, sequence optimization is vital for discovering and modifying therapeutic proteins and peptides for animal use. BioVenic also supports this technology for various animals, including companion pets, livestock, poultry, and fish industry, etc.
Protein and Peptide Molecular Modeling
Molecular modeling serves as a foundational tool, providing detailed insights into the structural configuration of proteins and peptides, which is crucial for identifying potential enhancements in their therapeutic actions. This computational technique involves simulating and analyzing the molecular and atomic interactions that govern the structure and function of biological molecules. In the context of veterinary medicine, molecular modeling is utilized to enhance the therapeutic efficacy and specificity of proteins and peptides designed to treat a variety of animal diseases. BioVenic offers comprehensive services in molecular modeling, providing tailored solutions that enhance protein and peptide lead optimization for veterinary applications, ensuring both efficacy and safety in therapeutic developments.
Fig.1 The workflow of protein molecular modeling. 1, 2
| Molecular Modeling | Description | Services |
|---|---|---|
| Proteins |
|
|
| Peptides |
|
|
Protein and Peptide Point Mutation
Meanwhile, point mutation techniques allow for precise alterations in the amino acid sequence, facilitating targeted improvements such as increased receptor affinity, enhanced stability, and reduced immunogenicity. Point mutation is a powerful tool in the biophysical sequence optimization of proteins and peptides, particularly in the development of veterinary therapeutics. This technique involves the deliberate alteration of specific amino acids within a protein or peptide sequence to improve its biological properties and therapeutic potential. BioVenic specializes in applying point mutation techniques for protein and peptide optimization, offering advanced point mutation methods and iterative testing services to enhance the efficacy and safety of veterinary therapeutics.
Fig.2 Point mutation scheme for the proteins.3
| Point Mutation | Description | Services |
|---|---|---|
| Proteins |
|
|
| Peptides |
|
|
Service Workflow
Our veterinary therapeutic protein and peptide optimization service begins with a comprehensive consultation, where we delve into your specific requirements to craft a project plan. Once the details are established, we secure the collaboration with a contract, ensuring transparency and mutual protection. We then rigorously conduct experiments following strict protocols and deliver a detailed analysis report. To further support our clients, we provide extensive post-project assistance and professional services, ensuring seamless implementation and practical application of the findings.
Fig.3 The veterinary therapeutic protein and peptide sequence optimization service workflow. (BioVenic Original)
Related Research
Recent advancements in computational protein modeling have integrated sequence-based machine learning with explicit physics-based simulations to enable precise, multi-scale evaluation of protein thermodynamic stability. By fine-tuning the transformer-based ProtT5 protein language model (PLM) on comprehensive mutational stability datasets, researchers demonstrated high-accuracy predictions of single- and multi-point mutation impacts across both monomeric tertiary structures and quaternary protein assemblies. Functional implications of these conformational alterations were validated using reporter models such as green fluorescent protein (GFP) brightness, establishing a direct link between sequence-level language representations and functional expression levels driven by protein folding efficiency. Furthermore, coupling these statistical PLM architectures with physics-based free energy perturbation (FEP) molecular dynamics simulations provided atomistic-level structural refinement and rigorous accounting for solvent dynamics, significantly boosting prediction accuracy for candidate stabilizing or destabilizing mutations at macromolecular interfaces. This hybrid paradigm underscores the value of combining parameter-efficient PLM fine-tuning with thermodynamic simulation frameworks to accurately navigate complex protein fitness landscapes for therapeutic and protein engineering applications.
Fig. 4 Graphical Abstract.4
Why Choose Us?
Advanced Bioinformatics Tools
BioVenic offers state-of-the-art tools designed for molecular modeling and point mutation analysis of therapeutic proteins and peptides in veterinary medicine.
Specialized in Sequence Optimization
Our team possesses deep expertise in optimizing protein and peptide sequences for veterinary applications, tailoring our approach to meet diverse objectives and requirements.
Innovative Analysis Methods
We utilize a variety of advanced analytical methods and software to interpret the outcomes of our therapeutic protein and peptide lead optimization processes.
Comprehensive After-sales Services
We provide detailed, extensive after-sales service to ensure that our clients fully comprehend and can effectively utilize their data, maximizing its impact and value.
Case Study
BioVenic turned a fragile veterinary therapeutic peptide into a development-ready candidate through sequence-level optimization. Molecular modeling located the promising positions, and iterative point mutations were introduced and tested one at a time: four beneficial changes accumulated to roughly double the peptide's relative stability, one step was kept as a deliberate stability-for-solubility trade-off, and activity assays confirmed the gains never compromised function. Every accepted change is documented against its measured contribution.
Fig. 5 Cumulative Effect of Point Mutations on Relative Peptide Stability Each Step Shows the Contribution of a Single Sequence Change
Frequently Asked Questions
Q1: What are the primary objectives of veterinary therapeutic protein and peptide sequence optimization?
A: The main goal is to enhance the pharmacological profile of biological molecules intended for animal health, specifically improving their stability, binding affinity, and half-life while reducing potential immunogenicity in target species. By utilizing computational modeling and rational design, we modify specific amino acid residues to optimize structural integrity and therapeutic efficacy. For any specific design constraints or target species-related parameters, we suggest consulting our technical support team to confirm the optimal strategy.
Q2: What input data or sequence formats do clients need to provide to initiate the optimization project?
A: Clients are generally requested to provide the primary amino acid sequence in standard FASTA format, along with any available structural data, functional activity benchmarks, or known expression system preferences. Detailed project requirements, such as target animal species (e.g., canine, bovine, swine) and specific improvement goals, help us tailor the computational workflow. If you have incomplete sequence information or proprietary data formats, we suggest consulting our technical support team to confirm the secure transmission requirements.
Q3: Can this optimization service accommodate different expression hosts for downstream manufacturing?
A: Yes, sequence optimization can be customized based on your intended manufacturing platform, whether utilizing mammalian cell lines, yeast, bacterial systems, or plant-based expression. Codon adaptation and avoidance of rare codons or unstable mRNA secondary structures are integrated into the sequence design to maximize recombinant protein yield and downstream recovery. For specific host compatibility questions or scale-up considerations, we suggest consulting our technical support team to confirm the most efficient expression design.
Protein and peptide sequence optimization is a complex field that demands specific expertise to select the most suitable methods for each project's unique goals. BioVenic provides a broad array of proprietary protein and peptide sequence optimization technologies, enhanced with the latest in bioinformatics and medicinal chemistry. With over a decade of experience in managing R&D projects, we are equipped to provide diverse modified proteins and peptides that meet your specific sequence optimization needs. Whether you have precise goals or are seeking professional advice, we encourage you to contact us today to discover how we can help you achieve the best outcomes.
References
- Mattapally, Saidulu, et al. "Computational modeling suggests impaired interactions between NKX2. 5 and GATA4 in individuals carrying a novel pathogenic D16N NKX2. 5 mutation." Oncotarget 9.17 (2018): 13713. https://doi.org/10.18632/oncotarget.24459.
- Image retrieved from Figure 1 "Scheme1: Flowchart of molecular modeling pipeline". Mattapally, Saidulu, et al., 2018, CC BY 3.0, the title was changed to "The workflow of protein molecular modeling ".
- Image retrieved from Wikipedia: By Jonsta247, https://commons.wikimedia.org/wiki/File:Point_mutations-en.png, Jonsta247, 2022, used under CC BY-SA 4.0
- Shiheido, Hirokazu, et al. "mRNA display selection of an optimized MDM2-binding peptide that potently inhibits MDM2-p53 interaction." PloS one 6.3 (2011): e17898. https://doi.org/10.3390/ijms26157125. Used under CC BY 4.0, without modification.